Share on
HTML EMBED
Click to Copy

Latest Episodes

Share on
HTML EMBED
Click to Copy
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Share on
HTML EMBED
Click to Copy
Marketplace
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Marketplace Morning Report
Share on
HTML EMBED
Click to Copy
Share on
HTML EMBED
Click to Copy

Theranos voids two years of botched blood-test results

Kai Ryssdal May 19, 2016
Share Now on:
HTML EMBED:
COPY
NBC's Maria Shriver, left, interviews Theranos Founder and CEO Elizabeth Holmes at the Vanity Fair New Establishment Summit in San Francisco in 2015.
Mike Windle/Getty Images

Theranos used to be one of the hottest names in Silicon Valley. Theranos and its founder and CEO, Elizabeth Holmes, were equally buzzy. This was due mostly to the company’s near-revolutionary blood-testing machine.

In the past six months or so, though, a good part of the shine has worn off.

Theranos’s testing results have come under serious scrutiny, and there was a new and troubling development Thursday. The “Wall Street Journal” reports that Theranos is now retracting blood-test results from its Edison machines due to potential errors.

John Carreyrou leads the coverage of Theranos for the Wall Street Journal and spoke with Kai Ryssdal.

 

How We Survive
How We Survive
Climate change is here. Experts say we need to adapt. This series explores the role of technology in helping humanity weather the changes ahead.